Search - tctmd.com

Displaying 781 - 800 of 1363

Sort: Relevancy | Date

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Caitlin E. Cox

February 07, 2020

News Daily News

Meat Consumption Linked to Small Rises in CVD, All-Cause Mortality Risks

Michael O'Riordan

February 05, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Daily News

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

L.A. McKeown

January 17, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Shelley Wood

January 14, 2020

News Daily News

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

Yael L. Maxwell

January 13, 2020

News Daily News

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

L.A. McKeown

January 09, 2020

News Daily News

Genetics Only Weakly Predicts Midlife BMI for Young Adults

Todd Neale

January 09, 2020

News Daily News

Giving Up Alcohol for Secondary Prevention of A-fib: New Insights

L.A. McKeown

January 07, 2020

News Daily News

Pulmonary Hypertension During Exercise Foretells Later Risk of Adverse CV Outcomes

Caitlin E. Cox

January 07, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

News Features

Year in Review: Physicians Pick the Biggest News of 2019

TCTMD News Team

December 30, 2019

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News

FDA Approves Icosapent Ethyl for Reducing CVD Events

Michael O'Riordan

December 13, 2019

News Daily News

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

Yael L. Maxwell

December 12, 2019

News Daily News

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Yael L. Maxwell

December 11, 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

Advertisement

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Meat Consumption Linked to Small Rises in CVD, All-Cause Mortality Risks

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

Genetics Only Weakly Predicts Midlife BMI for Young Adults

Giving Up Alcohol for Secondary Prevention of A-fib: New Insights

Pulmonary Hypertension During Exercise Foretells Later Risk of Adverse CV Outcomes

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

The Biggest News of 2019: TCTMD’s Top 10

Year in Review: Physicians Pick the Biggest News of 2019

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

FDA Approves Icosapent Ethyl for Reducing CVD Events

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content